EUVIMEDEUVIMED entdecken
Crossref

Eosinophilic granulomatosis with polyangiitis

Irina V. Stagnieva, Daria O. Zatulivetrova

Folia Otorhinolaryngologiae et Pathologiae Respiratoriae · 20.12.2025 · 31 (4) · 237-243

DOI: 10.17816/fopr702607 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Folia Otorhinolaryngologiae et Pathologiae Respiratoriae, online erschienen am 20.12.2025. Verfasst von Irina V. Stagnieva und 1 weiteren Autor:innen. Die Arbeit nennt 41 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare systemic disease in the group of ANCA-associated vasculitides, characterized by a combination of severe eosinophilic asthma, chronic rhinosinusitis, hypereosinophilia, and necrotizing vasculitis of small and medium-sized vessels. The rationale for this review stems from the considerable delay in EGPA diagnosis, the heterogeneity of clinical phenotypes, and the emergence of new therapeutic targets, which necessitates a synthesis of current data for practicing physicians. Based on the analysis of modern international consensus statements and scientific publications, the review systematizes data on the epidemiology, etiopathogenesis, classification, and clinical manifestations of EGPA. Particular attention is paid to the role of the cytokine profile (Th2, IL-5) and genetic predisposition in the formation of distinct disease endotypes (ANCA-positive and ANCA-negative), which determine disease course and response to therapy. The new 2022 ACR/EULAR classification criteria with high sensitivity and specificity are discussed in detail. The treatment section analyzes the evolution of therapeutic approaches: from standard immunosuppressive therapy with glucocorticoids and cyclophosphamide to modern targeted biological drugs, such as mepolizumab (anti-IL-5) and rituximab. The conclusion emphasizes that despite improved survival, traditional therapy remains associated with high toxicity and frequent relapses, making the development of personalized strategies based on endotyping a key direction in the management of patients with EGPA.

Zitieren

APA

Stagnieva, I. V., & Zatulivetrova, D. O. (2025). Eosinophilic granulomatosis with polyangiitis. Folia Otorhinolaryngologiae et Pathologiae Respiratoriae, 31(4), 237-243. https://doi.org/10.17816/fopr702607

Vancouver

Stagnieva IV, Zatulivetrova DO. Eosinophilic granulomatosis with polyangiitis. Folia Otorhinolaryngologiae et Pathologiae Respiratoriae. 2025;31(4):237-243. doi:10.17816/fopr702607

BibTeX
@article{Stagnieva2025,
  author = {Stagnieva, Irina V. and Zatulivetrova, Daria O.},
  title = {Eosinophilic granulomatosis with polyangiitis},
  journal = {Folia Otorhinolaryngologiae et Pathologiae Respiratoriae},
  year = {2025},
  volume = {31},
  number = {4},
  pages = {237--243},
  doi = {10.17816/fopr702607}
}
Kostenlos starten →